• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    63 Biggest Movers From Yesterday

    6/17/22 3:38:26 AM ET
    $ACIU
    $ACLX
    $ACOR
    $ADN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACIU alert in real time by email

    Gainers

    • Advent Technologies Holdings, Inc. (NYSE:ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
    • Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) gained 100.3% to close at $0.2820 after declining around 15% on Wednesday. Electric Last Mile Solutions recently announced plans to file for Chapter 7 bankruptcy.
    • Sidus Space, Inc. (NASDAQ:SIDU) shares climbed 63% to close at $7.63. Sidus Space shares jumped 225% on Wednesday after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity services contract with a potential value of $3.5 billion.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) jumped 54.5% to close at $0.6185 after the company announced Esteve Pharmaceuticals GmbH launched INBRIJA in Germany.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) gained 42.4% to close at $2.42 following’s Wednesday IPO.
    • Vivakor, Inc. (NASDAQ:VIVK) gained 40.7% to close at $2.49 after the company announced it signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City.
    • Cango Inc. (NYSE:CANG) jumped 40.2% to close at $3.14.
    • Pennsylvania Real Estate Investment Trust (NYSE:PEI) shares rose 34.8% to close at $5.32.
    • Decisionpoint Systems, Inc. (NYSE:DPSI) gained 34.9% to settle at $6.11.
    • Akanda Corp. (NASDAQ:AKAN) jumped 32.6% to close at $1.23.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) gained 25.4% to close at $12.41.
    • Lytus Technologies Holdings PTV. Ltd. (NYSE:LYT) climbed 24.9% to close at $21.25. Lytus Technologies priced its IPO at $4.75 per share.
    • Zhong Yang Financial Group Limited (NASDAQ:TOP) gained 24.8% to settle at $38.70.
    • Troika Media Group, Inc. (NASDAQ:TRKA) jumped 23.8% to settle at $0.9026.
    • Akero Therapeutics, Inc. (NASDAQ:AKRO) jumped 22% to close at $10.37. Akero Therapeutics announced a $25 million equity investment by Pfizer at $9.90 per share.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) jumped 20.7% to close at $14.30.
    • Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) climbed 19.7% to settle at $0.9751.
    • Alfi, Inc. (NASDAQ:ALF) jumped 18.5% to close at $1.28.
    • CinCor Pharma, Inc. (NASDAQ:CINC) rose 18.2% to close at $17.90. CinCor Pharma recently dosed first patient in the figHTN-CKD Phase 2 clinical study of its drug candidate Baxdrostat (CIN-107) for the treatment of patients with uncontrolled hypertension and chronic kidney disease (CKD).
    • SeaChange International, Inc. (NASDAQ:SEAC) jumped 17.3% to close at $0.6101.
    • Radius Health, Inc. (NASDAQ:RDUS) gained 17.1% to settle at $8.49.
    • Selecta Biosciences, Inc. (NASDAQ:SELB) jumped 16.5% to close at $1.34. Selecta Biosciences Director Carrie Smith Cox reported a purchase of 130,000 shares at $1.15 per share.
    • NextNav Inc. (NASDAQ:NN) surged 15.6% to close at $2.97. Nextnav 10%+ owner Wocap Global Opportunity Investment Partners, L.P. reported the purchase of 8,346,571 shares at at average price of $3.93 per share in Form 4 Filing on Wednesday.
    • Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) gained 15.4% to close at $10.19.
    • VIA optronics AG (NYSE:VIAO) gained 11.6% to close at $2.51.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) rose 11.5% to settle at $0.3010.
    • Bone Biologics Corporation (NASDAQ:BBLG) shares gained 10.8% to close at $1.33.
    • Bon Natural Life Limited (NASDAQ:BON) gained 7.9% to close at $3.70.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) shares gained 6.7% to close at $11.69 after gaining around 9% on Wednesday.

     

    Losers

    • EJF Acquisition Corp. (NASDAQ:EJFA) shares dropped 42.7% to close at $5.50.
    • Ebix, Inc. (NASDAQ:EBIX) shares tumbled 37.7% to close at $14.59 on Thursday.
    • PROG Holdings, Inc. (NYSE:PRG) declined 30.9% to close at $16.57 after the company cut FY22 adjusted EPS and sales guidance below estimates.
    • Hillstream BioPharma, Inc. (NASDAQ:HILS) fell 28.8% to close at $0.9116.
    • SpringBig Holdings (NASDAQ:SBIG) declined 28.7% to close at $3.21. springbig completed its merger with Tuatara Capital.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) fell 25.5% to close at $1.11.
    • AirSculpt Technologies, Inc. (NASDAQ:AIRS) tumbled 22.3% to close at $6.35. Morgan Stanley downgraded AirSculpt Technologies from Overweight to Equal-Weight and lowered the price target from $17 to $8.5.
    • Winc, Inc. (NYSE:WBEV) dropped 21.9% to close at $1.50.
    • Renovare Environmental, Inc. (NASDAQ:RENO) fell 21.8% to close at $0.1721.
    • Ambow Education Holding Ltd. (NYSE:AMBO) declined 21.8% to close at $0.36.
    • Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) fell 19.7% to close at $6.15.
    • Eros Media World Plc (NASDAQ:EMWP) dropped 18.3% to settle at $2.10.
    • AC Immune SA (NASDAQ:ACIU) fell 17.8% to close at $2.35 after the company announced crenezumab did not statistically significantly slow or prevent cognitive decline in people with a specific genetic mutation which causes early-onset Alzheimer's disease.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) dipped 17.8% to close at $0.7268. Aquestive Therapeutics announced topline results from the first three arms of Part 3 of the EPIPHAST study for its AQST-109 epinephrine oral film for allergic reactions, including anaphylaxis.
    • Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE:VLRS) fell 17.6% to close at $9.29.
    • Sonder Holdings Inc. (NASDAQ:SOND) dropped 17.4% to settle at $1.28.
    • Aspen Group, Inc. (NASDAQ:ASPU) fell 17.2% to close at $0.82.
    • StealthGas Inc. (NASDAQ:GASS) declined 17.1% to close at $3.39.
    • Beazer Homes USA, Inc. (NYSE:BZH) fell 16.9% to close at $10.65. B. Riley Securities maintained Beazer Homes USA with a Buy and lowered the price target from $23 to $19.
    • Yellow Corporation (NASDAQ:YELL) dropped 16.5% to close at $2.83.
    • FTC Solar, Inc. (NASDAQ:FTCI) fell 16.3% to settle at $4.16.
    • Outbrain Inc. (NASDAQ:OB) dropped 16.2% to close at $4.66. Jefferies maintained Outbrain with a Buy and lowered the price target from $9 to $8.
    • Shift Technologies, Inc. (NASDAQ:SFT) declined 16.2% to close at $0.6099.
    • Opendoor Technologies Inc. (NASDAQ:OPEN) fell 15.8% to settle at $4.32.
    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) fell 15.2% to close at $1.67.
    • Embark Technology, Inc. (NASDAQ:EMBK) fell 14.4% to close at $0.5575.
    • Arcellx, Inc. (NASDAQ:ACLX) fell 14% to close at $15.02. Arcellx priced an upsized underwritten follow-on offering of 7 million at $16 per share from the original 4 million shares.
    • IsoPlexis Corporation (NASDAQ:ISO) fell 13.6% to close at $2.10.
    • Sally Beauty Holdings, Inc. (NYSE:SBH) fell 12.7% to close at $11.75 after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered its price target from $19 to $12.
    • Cepton, Inc. (NASDAQ:CPTN) fell 11% to close at $1.29. Cepton, is set to join the Russell 3000® Index.
    • Green Giant Inc. (NASDAQ:GGE) declined 10.9% to close at $1.06.
    • SOPHiA GENETICS SA (NASDAQ:SOPH) fell 10.7% to close at $2.50.
    • Koninklijke Philips N.V. (NYSE:PHG) fell 9.6% to close at $20.44.
    • Missfresh Limited (NASDAQ:MF) fell 9.2% to close at $0.2249.
    Get the next $ACIU alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACIU
    $ACLX
    $ACOR
    $ADN

    CompanyDatePrice TargetRatingAnalyst
    Arcellx Inc.
    $ACLX
    10/16/2025$129.00Buy
    Stifel
    Akero Therapeutics Inc.
    $AKRO
    9/4/2025$72.00Buy
    H.C. Wainwright
    Controladora Vuela Compania de Aviacion S.A.B. de C.V.
    $VLRS
    8/22/2025$7.00Buy → Neutral
    Citigroup
    Opendoor Technologies Inc
    $OPEN
    8/13/2025$1.00Mkt Perform → Underperform
    Keefe Bruyette
    Opendoor Technologies Inc
    $OPEN
    8/7/2025Neutral → Sell
    Citigroup
    Akero Therapeutics Inc.
    $AKRO
    8/4/2025$76.00Buy
    TD Cowen
    Cango Inc.
    $CANG
    7/23/2025$8.00Buy
    H.C. Wainwright
    Controladora Vuela Compania de Aviacion S.A.B. de C.V.
    $VLRS
    7/23/2025$6.00 → $7.00Buy
    TD Cowen
    More analyst ratings

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NextNav and Oscilloquartz Successfully Integrate 5G-Based Timing for Critical Infrastructure Applications

    NextNav (NASDAQ:NN) and Oscilloquartz, an Adtran company, today announced a major milestone with the successful integration of NextNav 5G-based Positioning, Navigation, and Timing (PNT) technology and an Oscilloquartz GNSS-enabled grandmaster clock. This achievement marks a significant step towards the commercialization of a GPS complement and backup serving the needs of national security, public safety and mission critical enterprise timing applications Specifically, a NextNav 5G PRS-based timing receiver in combination with an Oscilloquartz grandmaster clock successfully produced a GPS-quality timing output signal in the absence of GPS in both outdoor and indoor environments. Fusion of

    10/24/25 1:54:00 PM ET
    $ADTN
    $NN
    Telecommunications Equipment
    Utilities
    Industrial Machinery/Components
    Industrials

    Vivakor Announces Pricing of $3.5 Million Registered Direct Offering of Common Stock and Pre-Funded Warrants

    Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Vivakor, Inc. ("Vivakor" or the "Company") (NASDAQ:VIVK), an integrated energy infrastructure & environmental services company, today announced that it has entered into securities purchase agreements with a single fundamental institutional investor for the purchase and sale of 10,909,090 shares of its common stock and 5,000,000 pre-funded warrants in a registered direct offering, for gross proceeds of approximately $3.5 million, before deducting commissions and offering expenses. The closing of the offering is expected to occur on or about October 27, 2025, subject to the satisfaction of customary closing conditions. D. Boral Capital LLC is ac

    10/24/25 1:40:00 PM ET
    $VIVK
    Environmental Services
    Utilities

    First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune's ACI-19626 in Precision Medicine

    First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune's ACI-19626 in Precision Medicine Aggregated TDP-43 is a pathological hallmark of neurodegenerative diseases including ALS, FTD and LATE, and a co-pathology in Alzheimer's and Parkinson's diseasesPET imaging of aggregated TDP-43 could facilitate precision medicine in these diseases, whose shared clinical features complicate differential diagnosis, potentially delaying therapyBased on specificity, sensitivity, and pharmacokinetic properties, ACI-19626 was advanced into a Phase 1 clinical study with initial readout expected in Q4 2025 Lausanne, Switzerland, October 24, 2025 -- AC

    10/24/25 8:50:00 AM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACIU
    $ACLX
    $ACOR
    $ADN
    SEC Filings

    View All

    Sonder Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

    8-K - Sonder Holdings Inc. (0001819395) (Filer)

    10/24/25 4:05:37 PM ET
    $SOND
    Hotels/Resorts
    Consumer Discretionary

    SEC Form PREM14A filed by Akero Therapeutics Inc.

    PREM14A - Akero Therapeutics, Inc. (0001744659) (Filer)

    10/24/25 3:51:33 PM ET
    $AKRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vivakor Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Vivakor, Inc. (0001450704) (Filer)

    10/23/25 5:28:43 PM ET
    $VIVK
    Environmental Services
    Utilities

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wu Eric Chung-Wei bought $2,000,001 worth of shares (300,752 units at $6.65), increasing direct ownership by 18% to 1,950,636 units (SEC Form 4)

    4 - Opendoor Technologies Inc. (0001801169) (Issuer)

    9/30/25 4:06:59 PM ET
    $OPEN
    Real Estate
    Finance

    Director Wu Eric Chung-Wei bought $2,999,995 worth of shares (451,127 units at $6.65), increasing direct ownership by 38% to 1,649,884 units (SEC Form 4)

    4 - Opendoor Technologies Inc. (0001801169) (Issuer)

    9/15/25 5:50:24 PM ET
    $OPEN
    Real Estate
    Finance

    Director Rangel Max R. bought $49,239 worth of shares (3,500 units at $14.07) (SEC Form 4)

    4 - Sally Beauty Holdings, Inc. (0001368458) (Issuer)

    9/8/25 9:00:05 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $ACIU
    $ACLX
    $ACOR
    $ADN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TYMLOS issued to RADIUS HEALTH INC

    Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-13) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/19/2022. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy

    12/21/22 4:37:57 AM ET
    $RDUS
    Industrial Specialties
    Consumer Discretionary

    FDA Approval for TYMLOS issued to RADIUS HEALTH INC

    Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-10) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/22/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy

    12/23/21 5:39:20 PM ET
    $RDUS
    Industrial Specialties
    Consumer Discretionary

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner South Cone Investments Limited Partnership sold $15,711,314 worth of shares (5,923,000 units at $2.65) (SEC Form 4)

    4 - Rani Therapeutics Holdings, Inc. (0001856725) (Issuer)

    10/22/25 6:57:28 PM ET
    $RANI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Operating Officer Aminpour Sasan

    4 - FTC Solar, Inc. (0001828161) (Issuer)

    10/22/25 5:11:04 PM ET
    $FTCI
    Semiconductors
    Technology

    SEC Form 4 filed by CHIEF FINANCIAL OFFICER Behnen Cathy

    4 - FTC Solar, Inc. (0001828161) (Issuer)

    10/22/25 5:09:47 PM ET
    $FTCI
    Semiconductors
    Technology

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Arcellx with a new price target

    Stifel initiated coverage of Arcellx with a rating of Buy and set a new price target of $129.00

    10/16/25 8:52:04 AM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    H.C. Wainwright resumed coverage on Akero Therapeutics with a new price target

    H.C. Wainwright resumed coverage of Akero Therapeutics with a rating of Buy and set a new price target of $72.00

    9/4/25 8:59:48 AM ET
    $AKRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Volaris Aviation downgraded by Citigroup with a new price target

    Citigroup downgraded Volaris Aviation from Buy to Neutral and set a new price target of $7.00

    8/22/25 7:59:12 AM ET
    $VLRS
    Air Freight/Delivery Services
    Consumer Discretionary

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Leadership Updates

    Live Leadership Updates

    View All

    Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

    SAN JOSE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (NASDAQ:RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the appointment of Abraham ("Abe") Bassan and Vasudev Bailey, Ph.D., to its Board of Directors. In conjunction with the new appointments, Andrew Farquharson and Maulik Nanavaty have stepped down from the Board of Directors. "We are thrilled to welcome Abe and Vasudev to our Board of Directors as we enter an exciting new era for Rani, highlighted by both our clinical-stage pipeline and expansion opportunities into high-value therapeutics from our rece

    10/23/25 4:01:45 PM ET
    $RANI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NextNav Appoints Industry Veteran Tim Gray as Chief Financial Officer

    Chris Gates to Lead Corporate Development Leadership team expanded to pursue next chapter of anticipated growth NextNav Inc. (NASDAQ:NN), a leader in next generation positioning, navigation, and timing (PNT) and 3D geolocation, today announced the appointment of Tim Gray as Chief Financial Officer. Chris Gates, the Company's former CFO, will now focus his time on strategy as Executive Vice President of Corporate Development. "As we prepare for the commercialization of our technology, I'm excited to welcome Tim, who provides a rare combination of deep spectrum knowledge and experience leading the finance function at a growth-oriented company with technology in the marketplace," said Ma

    9/22/25 8:30:00 AM ET
    $NN
    Industrial Machinery/Components
    Industrials

    Sidus Space Appoints Lawrence Hollister as Chief Business Officer to Drive Strategic Growth and Market Expansion

    Sidus Space (NASDAQ:SIDU), (the "Company" or "Sidus"), an innovative space and defense technology company, today announced the appointment of Lawrence Hollister as its new Chief Business Officer, effective September 15, 2025, to accelerate growth across commercial and government markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915521625/en/Sidus Space Appoints Lawrence Hollister as Chief Business Officer Mr. Hollister joins Sidus with a distinguished track record of driving revenue growth, scaling operations, and executing strategic initiatives across defense, aerospace, intelligence, cyber, and federal civil sectors.

    9/15/25 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Financials

    Live finance-specific insights

    View All

    PROG Holdings Reports Third Quarter 2025 Results

    Consolidated revenues of $595.1 million; Net earnings of $33.1 million Adjusted EBITDA of $67.0 million Diluted EPS of $0.82; Non-GAAP Diluted EPS of $0.90 Progressive Leasing GMV of $410.9 million Four Technologies grows GMV 162.8%; third consecutive quarter of positive Adjusted EBITDA PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Vive Financial, Four Technologies, and Build, today announced financial results for the third quarter ended September 30, 2025. "Our third quarter results once again highlight the strength and consistency of our execution, even as consumers face ongoing economic pressures," said Steve Michaels, President an

    10/22/25 7:30:00 AM ET
    $PRG
    Diversified Commercial Services
    Consumer Discretionary

    NextNav Announces Date for Third Quarter 2025 Earnings Call

    NextNav Inc. ("NextNav") (NASDAQ:NN), a leader in next generation positioning, navigation, and timing (PNT) and 3D geolocation, today announced that it will release its financial results for the third quarter ended September 30, 2025 before market open on Thursday, November 6, 2025, and will host a conference call on the same day at 9:00 AM ET to discuss its results. Registration for the conference call can be completed by visiting the following website prior to, or on the day of, the conference call: https://events.q4inc.com/attendee/320866830. After registering, each participant will be provided with call details and a registrant ID. Reminders will also be sent to registered participant

    10/21/25 9:00:00 AM ET
    $NN
    Industrial Machinery/Components
    Industrials

    SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025

    BOSTON and ROLLE, Switzerland, Oct. 21, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third quarter 2025 before U.S. markets open on Tuesday, November 4, 2025. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET. The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be available on the

    10/21/25 8:00:00 AM ET
    $SOPH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AC Immune SA

    SC 13G/A - AC Immune SA (0001651625) (Subject)

    12/13/24 5:15:16 PM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by StealthGas Inc.

    SC 13D/A - StealthGas Inc. (0001328919) (Subject)

    12/9/24 3:53:05 PM ET
    $GASS
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by NextNav Inc.

    SC 13D/A - NEXTNAV INC. (0001865631) (Subject)

    12/6/24 6:03:25 PM ET
    $NN
    Industrial Machinery/Components
    Industrials